Literature DB >> 18726898

AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.

Elias Spanakis1, Edrice Milord, Claudia Gragnoli.   

Abstract

Almost 90% of nephrogenic diabetes insipidus (NDI) is due to mutations in the arginine-vasopressin receptor 2 gene (AVPR2). We retrospectively examined all the published mutations/variants in AVPR2. We planned to perform a comprehensive review of all the AVPR2 mutations/variants and to test whether any amino acid change causing a missense mutation is significantly more or less common than others. We performed a Medline search and collected detailed information regarding all AVPR2 mutations and variants. We performed a frequency comparison between mutated and wild-type amino acids and codons. We predicted the mutation effect or reported it based on published in vitro studies. We also reported the ethnicity of each mutation/variant carrier. In summary, we identified 211 AVPR2 mutations which cause NDI in 326 families and 21 variants which do not cause NDI in 71 NDI families. We described 15 different types of mutations including missense, frameshift, inframe deletion, deletion, insertion, nonsense, duplication, splicing and combined mutations. The missense mutations represent the 55.83% of all the NDI published families. Arginine and tyrosine are significantly (P = 4.07E-08 and P = 3.27E-04, respectively) the AVPR2 most commonly mutated amino acids. Alanine and glutamate are significantly (P = 0.009 and P = 0.019, respectively) the least mutated AVPR2 amino acids. The spectrum of mutations varies from rare gene variants or polymorphisms not causing NDI to rare mutations causing NDI, among which arginine and tyrosine are the most common missense. The AVPR2 mutations are spread world-wide. Our study may serve as an updated review, comprehensive of all AVPR2 variants and specific gene locations. J. Cell. Physiol. 217: 605-617, 2008. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726898     DOI: 10.1002/jcp.21552

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  43 in total

1.  Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.

Authors:  Duygu Duzenli; Emel Saglar; Ferhat Deniz; Omer Azal; Beril Erdem; Hatice Mergen
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.

Authors:  Emel Saglar; Ferhat Deniz; Beril Erdem; Tugce Karaduman; Arif Yönem; Eylem Cagiltay; Hatice Mergen
Journal:  Endocrine       Date:  2013-09-13       Impact factor: 3.633

3.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

Review 4.  Avian genomics lends insights into endocrine function in birds.

Authors:  C V Mello; P V Lovell
Journal:  Gen Comp Endocrinol       Date:  2017-06-17       Impact factor: 2.822

5.  Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.

Authors:  Jing Cen; Min Nie; Lian Duan; Feng Gu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 6.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

Review 7.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

8.  Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.

Authors:  Sayali A Ranadive; Baran Ersoy; Helene Favre; Clement C Cheung; Stephen M Rosenthal; Walter L Miller; Christian Vaisse
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-18       Impact factor: 3.478

9.  Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis.

Authors:  Yoon Hi Cho; Stephen Gitelman; Stephen Rosenthal; Geoffrey Ambler
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-28

10.  Involvement of the V2 vasopressin receptor in adaptation to limited water supply.

Authors:  Iris Böselt; Holger Römpler; Thomas Hermsdorf; Doreen Thor; Wibke Busch; Angela Schulz; Torsten Schöneberg
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.